Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Expense ratio
- Unavailable
- Net assets
- $20.7M
- Holdings
- 73
- 12-month distribution yield
- 0.39%
- Asset class
- Derivatives-based
Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) is an exchange-traded fund listed on NYSE Arca in the United States, issued by Direxion. Its category is Derivatives-based. Its last price was US$15.16 on 20 Oct 2026. It reported net assets of US$20.65 million as of 31 Jul 2026. Its latest holdings report lists 73 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$0.0590 a unit, a 12-month distribution yield of 0.39%, paid quarterly.
Fees
No expense ratio found
Size and reporting
- Net assets
- $20,650,898
- Total assets
- $26,614,473
- Holdings as of
- 31 Jul 2026
- Report made public
- 28 Sep 2026 (59 days after the month end)
Top holdings
Largest 25 of 73 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | GOLDMAN FINANCIAL GOLDMAN FINL SQ TRSRY INST 506 | No identifier reported | 22.36% | $4.6M | Short-term investment vehicles (cash funds) | United States | USD |
| 2 | S&P PHARMACEUTICALS SELECT INDEX SWAP | No identifier reported | 16.36% | $3.4M | Other derivatives | United States | USD |
| 3 | DREYFUS DREYFUS GOV'T CASH MGMT -INSTITUTIONAL CUSIP 262006208 DGCXX (#289) | No identifier reported | 8.14% | $1.7M | Short-term investment vehicles (cash funds) | United States | USD |
| 4 | S&P PHARMACEUTICALS SELECT INDEX SWAP | No identifier reported | 7.41% | $1.5M | Other derivatives | United States | USD |
| 5 | CRINETICS PHARMACEUTICALS IN | US22663K1079 | 2.77% | $572K | Equity (common) | United States | USD |
| 6 | MBX BIOSCIENCES INC | US55287L1017 | 2.42% | $500K | Equity (common) | United States | USD |
| 7 | S&P PHARMACEUTICALS SELECT INDEX SWAP | No identifier reported | -2.28% | -$471K | Other derivatives | United States | USD |
| 8 | ATAIBECKLEY INC | US04650F1012 | 2.16% | $446K | Equity (common) | United States | USD |
| 9 | Definium Therapeutics, Inc | 24477V105 | 2.13% | $440K | Equity (common) | Canada | USD |
| 10 | GOLDMAN SACHS LIQ ES FD A GOLDMAN SACHS FIN GOV 465 INSTITUT | No identifier reported | 2.03% | $420K | Short-term investment vehicles (cash funds) | United States | USD |
| 11 | AMYLYX PHARMACEUTICALS INC | US03237H1014 | 1.72% | $354K | Equity (common) | United States | USD |
| 12 | ENLIVEN THERAPEUTICS INC | US29337E1029 | 1.68% | $348K | Equity (common) | United States | USD |
| 13 | CORCEPT THERAPEUTICS INC Corcept Therapeutics Inc. COM STK USD0.00001 | US2183521028 | 1.67% | $344K | Equity (common) | United States | USD |
| 14 | ALUMIS INC | US0223071020 | 1.60% | $331K | Equity (common) | United States | USD |
| 15 | NUVATION BIO INC | US67080N1019 | 1.57% | $325K | Equity (common) | United States | USD |
| 16 | TREVI THERAPEUTICS INC | US89532M1018 | 1.55% | $320K | Equity (common) | United States | USD |
| 17 | LIQUIDIA CORP | US53635D2027 | 1.47% | $303K | Equity (common) | United States | USD |
| 18 | NEKTAR THERAPEUTICS | US6402683063 | 1.42% | $292K | Equity (common) | United States | USD |
| 19 | AMNEAL PHARMACEUTICALS INC | US03168L1052 | 1.36% | $281K | Equity (common) | United States | USD |
| 20 | BRISTOL-MYERS SQUIBB CO Bristol-Myers Squibb Company COM USD0.10 | US1101221083 | 1.34% | $276K | Equity (common) | United States | USD |
| 21 | EDGEWISE THERAPEUTICS INC | US28036F1057 | 1.33% | $274K | Equity (common) | United States | USD |
| 22 | OMEROS CORP | US6821431029 | 1.32% | $273K | Equity (common) | United States | USD |
| 23 | LIGAND PHARMACEUTICALS Ligand Pharmaceuticals Incorporated 'B'COM USD0.001 | US53220K5048 | 1.32% | $272K | Equity (common) | United States | USD |
| 24 | ELANCO ANIMAL HEALTH INC Elanco Animal Health Inc COM NPV | US28414H1032 | 1.31% | $271K | Equity (common) | United States | USD |
| 25 | VERADERMICS INC | US9229671048 | 1.28% | $265K | Equity (common) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Warning: Uses derivatives
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 75.02% | |
| Short-term investment vehicles (cash funds) | 32.53% | |
| Other derivatives | 22.08% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 127.50% | |
| Canada | 2.13% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 129.63% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 24.27% | |
| Health Technology | 2.77% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $0.0590
- 12-month yield
- 0.39%
- Frequency
- Quarterly
- Latest ex-date
- 22 Sep 2026
12-month yield = distributions per unit with an ex-date in the last 12 months ($0.0590) ÷ latest price ($15.16) × 100 = 0.39%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (19 payments)
| Ex-date | Amount per unit |
|---|---|
| 22 Sep 2026 | $0.0010 |
| 23 Jun 2026 | $0.0150 |
| 24 Mar 2026 | $0.0100 |
| 23 Dec 2025 | $0.0330 |
| 23 Sep 2025 | $0.0100 |
| 24 Jun 2025 | $0.0240 |
| 25 Mar 2025 | $0.0180 |
| 23 Dec 2024 | $0.0130 |
| 24 Sep 2024 | $0.0290 |
| 25 Jun 2024 | $0.0220 |
| 19 Mar 2024 | $0.0270 |
| 21 Dec 2023 | $0.0380 |
| 19 Sep 2023 | $0.0350 |
| 21 Jun 2023 | $0.0490 |
| 21 Mar 2023 | $0.0190 |
| 20 Dec 2022 | $0.0320 |
| 20 Sep 2022 | $0.0170 |
| 22 Jun 2022 | $0.0040 |
| 22 Mar 2022 | $0.0080 |
Filings and sources
Compare with
Largest funds in the same category:
- PILL and TQQQ ProShares UltraPro QQQ
- PILL and SOXL Direxion Daily Semiconductor Bull 3X ETF
- PILL and BBJP JPMorgan BetaBuilders Japan ETF
- PILL and QLD ProShares Ultra QQQ